Literature DB >> 16308343

"Periodic fever" without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis.

T Kallinich1, D Haffner, B Rudolph, R Schindler, S Canaan-Kühl, R Keitzer, G R Burmester, A Roesen-Wolff, J Roesler.   

Abstract

BACKGROUND: Tumour necrosis factor (TNF) receptor associated periodic syndrome (TRAPS) is caused by dominant mutations in the TNFRSF1A gene. In typical cases TRAPS begins early in childhood and is characterised by high and remittent fever over a period of 1-4 weeks or longer, accompanied by systemic and local inflammation. CASE REPORTS: Patient 1 presented with recurrent episodes of weakness, migrating myalgias, arthralgias, exanthema, and chest pain lasting for 1-4 weeks, but without any fever over an initial period of 4 years at least. Diagnosis of TRAPS was confirmed by the heterozygous mutation Y20H in TNFRSF1A. Patient 2, a 23 year old woman never had any symptoms indicative of TRAPS. Genetic evaluation of all members of her family with a TRAPS index patient disclosed the T50M mutation in TNFRSF1A. A medical check up showed proteinuria, and renal biopsy disclosed AA amyloidosis.
CONCLUSIONS: TRAPS associated mutations can induce considerable inflammation that is not necessarily accompanied by fever. Even monosymptomatic severe amyloidosis can occur in these patients. Genetic counselling and appropriate management to prevent or mitigate amyloidosis may be necessary.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16308343      PMCID: PMC1798226          DOI: 10.1136/ard.2005.043570

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome.

Authors:  E Drewe; E M McDermott; R J Powell
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

2.  Periodic fever (TRAPS) caused by mutations in the TNFalpha receptor 1 (TNFRSF1A) gene of three German patients.

Authors:  A Rösen-Wolff; H W Kreth; S Hofmann; K Höhne; G Heubner; D Möbius; F Zintl; M Gahr; J Roesler
Journal:  Eur J Haematol       Date:  2001-08       Impact factor: 2.997

3.  Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients.

Authors:  E Drewe; E M McDermott; P T Powell; J D Isaacs; R J Powell
Journal:  Rheumatology (Oxford)       Date:  2003-02       Impact factor: 7.580

4.  Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis.

Authors:  Tilmann Kallinich; Sonia Briese; Joachim Roesler; Birgit Rudolph; Nanette Sarioglu; Oliver Blankenstein; Rolf Keitzer; Uwe Querfeld; Dieter Haffner
Journal:  J Rheumatol       Date:  2004-12       Impact factor: 4.666

Review 5.  TNFRSF1A-associated periodic syndrome (TRAPS), Muckle-Wells syndrome (MWS) and renal amyloidosis.

Authors:  Catherine Dodé; Laurence Cuisset; Marc Delpech; Gilles Grateau
Journal:  J Nephrol       Date:  2003 May-Jun       Impact factor: 3.902

6.  The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome.

Authors:  Catherine Dodé; Marc André; Thierry Bienvenu; Pierre Hausfater; Christophe Pêcheux; Jacques Bienvenu; Jean-Claude Lecron; Philippe Reinert; Daniel Cattan; Jean-Charles Piette; Marie-France Szajnert; Marc Delpech; Gilles Grateau
Journal:  Arthritis Rheum       Date:  2002-08

7.  Mutational spectrum in the MEFV and TNFRSF1A genes in patients suffering from AA amyloidosis and recurrent inflammatory attacks.

Authors:  Catherine Dodé; Bouke P C Hazenberg; Christophe Pêcheux; Daniel Cattan; Bruno Moulin; Anne Barthélémy; Marie-Claire Gubler; Marc Delpech; Gilles Grateau
Journal:  Nephrol Dial Transplant       Date:  2002-07       Impact factor: 5.992

Review 8.  The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations.

Authors:  Keith M Hull; Nitza Shoham; Jae Jin Chae; Ivona Aksentijevich; Daniel L Kastner
Journal:  Curr Opin Rheumatol       Date:  2003-01       Impact factor: 5.006

Review 9.  The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.

Authors:  Keith M Hull; Elizabeth Drewe; Ivona Aksentijevich; Harjot K Singh; Kondi Wong; Elizabeth M McDermott; Jane Dean; Richard J Powell; Daniel L Kastner
Journal:  Medicine (Baltimore)       Date:  2002-09       Impact factor: 1.889

10.  Infevers: an evolving mutation database for auto-inflammatory syndromes.

Authors:  Isabelle Touitou; Suzanne Lesage; Michael McDermott; Laurence Cuisset; Hal Hoffman; Catherine Dode; Nitza Shoham; Ebun Aganna; Jean-Pierre Hugot; Carol Wise; Hans Waterham; Denis Pugnere; Jacques Demaille; Cyril Sarrauste de Menthiere
Journal:  Hum Mutat       Date:  2004-09       Impact factor: 4.878

View more
  10 in total

Review 1.  [Diagnostics and therapy of AA amyloidosis].

Authors:  N Blank; H M Lorenz
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

Review 2.  Current knowledge on procaspase-1 variants with reduced or abrogated enzymatic activity in autoinflammatory disease.

Authors:  Hella Luksch; Stefan Winkler; Michael C Heymann; Felix Schulze; Sigrun R Hofmann; Joachim Roesler; Angela Rösen-Wolff
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

3.  Variable intrafamilial expressivity of the rare tumor necrosis factor-receptor associated periodic syndrome-associated mutation I170N that affects the TNFR1A cleavage site.

Authors:  Petra Lehmann; Bernd Salzberger; Peter Haerle; Ivona Aksentijevich; Daniel Kastner; Juergen Schoelmerich; Stephanie Rosenfeld; Ulf Mueller-Ladner
Journal:  Mod Rheumatol       Date:  2010-02-19       Impact factor: 3.023

Review 4.  The spectrum of autoinflammatory diseases: recent bench to bedside observations.

Authors:  John G Ryan; Raphaela Goldbach-Mansky
Journal:  Curr Opin Rheumatol       Date:  2008-01       Impact factor: 5.006

Review 5.  Monogenic autoinflammatory diseases: concept and clinical manifestations.

Authors:  Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Clin Immunol       Date:  2013-04-09       Impact factor: 3.969

Review 6.  [Caspase-1 regulates autoinflammation in rheumatic diseases].

Authors:  S Winkler; C M Hedrich; A Rösen-Wolff
Journal:  Z Rheumatol       Date:  2016-04       Impact factor: 1.372

7.  Periodic Fever: a review on clinical, management and guideline for Iranian patients - part I.

Authors:  Zahra Ahmadinejad; Sedigeh Mansori; Vahid Ziaee; Neda Alijani; Yahya Aghighi; Nima Parvaneh; Mohammad-Hassan Mordinejad
Journal:  Iran J Pediatr       Date:  2013-11-16       Impact factor: 0.364

8.  Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management.

Authors:  Divya Shakti; Rebecca Hehn; Kimberly Gauvreau; Robert P Sundel; Jane W Newburger
Journal:  J Am Heart Assoc       Date:  2014-11-07       Impact factor: 5.501

Review 9.  Lung Involvement in Children with Hereditary Autoinflammatory Disorders.

Authors:  Giusyda Tarantino; Susanna Esposito; Laura Andreozzi; Benedetta Bracci; Francesca D'Errico; Donato Rigante
Journal:  Int J Mol Sci       Date:  2016-12-15       Impact factor: 5.923

Review 10.  NF-κB: At the Borders of Autoimmunity and Inflammation.

Authors:  Laura Barnabei; Emmanuel Laplantine; William Mbongo; Frédéric Rieux-Laucat; Robert Weil
Journal:  Front Immunol       Date:  2021-08-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.